|

PIN +anti-PD1 Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 2

Top Sponsors

  • Chinese PLA General Hospital2

Indications

  • Adult2
  • Cancer2
  • Liver Disease1
  • Solid Tumor1
  • Liver Cancer1

Other2 trials

PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma
Phase 1
PIN in Combination With Anti-PD1 in Previously Treated Solid Tumor
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.